KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Royalty Pharma (RPRX) Intangibles: 2019-2021

Historic Intangibles for Royalty Pharma (RPRX) over the last 3 years, with Dec 2021 value amounting to $5.7 million.

  • Royalty Pharma's Intangibles fell 80.22% to $5.7 million in Q4 2021 from the same period last year, while for Dec 2021 it was $5.7 million, marking a year-over-year decrease of 80.22%. This contributed to the annual value of $5.7 million for FY2021, which is 80.22% down from last year.
  • According to the latest figures from FY2021, Royalty Pharma's Intangibles is $5.7 million, which was down 80.22% from $28.7 million recorded in FY2020.
  • Over the past 5 years, Royalty Pharma's Intangibles peaked at $51.7 million during FY2019, and registered a low of $5.7 million during FY2021.
  • Over the past 3 years, Royalty Pharma's median Intangibles value was $28.7 million (recorded in 2020), while the average stood at $28.7 million.
  • Data for Royalty Pharma's Intangibles shows a maximum YoY plummeted of 80.22% (in 2021) over the last 5 years.
  • Over the past 3 years, Royalty Pharma's Intangibles (Yearly) stood at $51.7 million in 2019, then crashed by 44.58% to $28.7 million in 2020, then plummeted by 80.22% to $5.7 million in 2021.